Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function

Obesity (Silver Spring). 2012 Oct;20(10):2057-62. doi: 10.1038/oby.2012.56. Epub 2012 Mar 8.

Abstract

Diet-induced weight loss in women may be associated with decreases not only in plasma levels of low-density lipoprotein cholesterol (LDL-C), but also in high-density lipoprotein cholesterol (HDL-C). Whether a decrease in HDL-C is associated with altered HDL function is unknown. One hundred overweight or obese women (age 46 ± 11 years, 60 black; 12 diabetic) were enrolled in the 6-month program of reduced fat and total energy diet and low-intensity exercise. Serum cholesterol efflux capacity was measured in (3)H-cholesterol-labeled BHK cells expressing ABCA1, ABCG1, or SR-B1 transporters and incubated with 1% apolipoprotein B (apoB)-depleted serum. Antioxidant properties of HDL were estimated by paraoxonase-1 (PON1) activity and oxygen radical absorbance capacity (ORAC). Endothelial nitric oxide synthase (eNOS) activation was measured by conversion of L-arginine to L-citrulline in endothelial cells incubated with HDL from 49 subjects. Participants achieved an average weight loss of 2.2 ± 3.9 kg (P < 0.001), associated with reductions in both LDL-C (-6 ± 21 mg/dl, P = 0.004) and HDL-C (-3 ± 9 mg/dl, P = 0.016). Cholesterol efflux capacity by the ABCA1 transporter decreased by 10% (P = 0.006); efflux capacities by the ABCG1 and SR-B1 transporters were not significantly altered. ORAC decreased by 15% (P = 0.018); neither PON1 activity nor eNOS activation was significantly altered by reduction in HDL-C. Findings were similar for diabetic and nondiabetic subjects. Diet-induced weight loss in overweight or obese women is associated with a decrease in HDL-C levels, but overall HDL function is relatively spared, suggesting that decrease in HDL-C in this setting is not deleterious to cardiovascular risk.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Absorptiometry, Photon
  • Adiposity
  • Adult
  • Aryldialkylphosphatase / blood
  • Body Mass Index
  • Cholesterol, HDL / blood*
  • Cholesterol, LDL / blood
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / physiopathology
  • Diet, Fat-Restricted*
  • Endothelium, Vascular / metabolism*
  • Endothelium, Vascular / physiopathology
  • Exercise*
  • Female
  • Humans
  • Insulin Resistance
  • Middle Aged
  • Nitric Oxide Synthase Type III / blood
  • Obesity / blood*
  • Obesity / epidemiology
  • Obesity / physiopathology
  • Risk Assessment
  • United States / epidemiology
  • Weight Loss*

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Aryldialkylphosphatase
  • PON1 protein, human